The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass

A highly sensitive adenylate cyclase assay

1974 • 4,213 citations

Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide

1992 • 752 citations

The VIP₂ receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

1993 • 496 citations

Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions

1994 • 424 citations

Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.

1994 • 248 citations

Type I receptors for PACAP (a neuropeptide even more important than VIP?)

1993 • 201 citations

Molecular Cloning and Functional Characterization of a Human VIP Receptor from SUP-T1 Lymphoblasts

1994 • 162 citations

Human Intestinal VIP Receptor: Cloning and Functional Expression of Two cDNA Encoding Proteins with Different N-Terminal Domains

1994 • 149 citations

Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4‐2J

1990 • 127 citations

PACAP, PACAP receptors, and intracellular signalling

1994 • 88 citations

Structure-activity studies of vasoactive intestinal polypeptide.

1991 • 78 citations

Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors

1995 • 75 citations

Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies.

1994 • 67 citations

A new type of functional VIP receptor has an affinity for helodermin in human SUP‐T1 lymphoblasts

1988 • 62 citations

Properties of the VIP-PACAP type II receptor stably expressed in CHO cells

1994 • 59 citations

Chemical, immunological and biological properties of peptides like vasoactive‐intestinal‐peptide and peptide‐histidine‐isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum)

1987 • 58 citations

Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis.

1994 • 52 citations

Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells

1995 • 51 citations

Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines

1990 • 41 citations

PACAP acts through VIP type 2 receptors in the rat testis

1995 • 40 citations

Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.

1994 • 39 citations

Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes

1989 • 38 citations

Characterization of the VIP receptor from SUP T1 lymphoblasts

1996 • 27 citations

Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide.

1990 • 25 citations

Properties of vasoactive‐intestinal‐peptide receptors and β‐adrenoceptors in the murine radiation leukemia‐virus‐induced lymphoma cell line BL/VL₃

1989 • 17 citations

Effect of Vasoactive Intestinal Peptide in Man

1988 • 12 citations

Adenylate cyclase activation by VIP-helodermin and histamine H2 receptors in human THP-1 monocytes/macrophages: A possible role in the regulation of superoxide anions production

1989 • 10 citations

Vasoactive Intestinal Peptide Pituitary Adenylate Cyclase Activating Polypeptide and Related Regulatory Peptides

1994 • 9 citations

Degradation of vasoactive intestinal peptide in bronchial alveolar lavage fluid

1992 • 8 citations